Cargando…
Evaluating the Impact of Long-Term Outpatient Ertapenem (ETP) vs. Ceftriaxone (CTX) on Clinical Success and Development of Resistance for Documented Enterobacteriaceae Infections
BACKGROUND: Ceftriaxone and ertapenem are two commonly prescribed outpatient once-daily parenteral antimicrobials with activity against Enterobacteriaceae. However, there is minimal data evaluating the impact of long-term CTX and ETP therapy on development of resistance. Therefore, the goals of this...
Autores principales: | Carver, Peggy, Michael, Craig, Facchini, Victoria, Koseck, Anna, Edge, Corey, Nagel, Jerod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631122/ http://dx.doi.org/10.1093/ofid/ofx163.1317 |
Ejemplares similares
-
Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae
por: Gubenšek, Urša, et al.
Publicado: (2022) -
2266. Management of Ertapenem-Resistant, Meropenem-Susceptible Enterobacteriaceae
por: Srinivas, Pavithra, et al.
Publicado: (2019) -
1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019) -
Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia
por: Lee, Chen-Hsiang, et al.
Publicado: (2018) -
Origins of ETP leukemia
por: Booth, Christopher A. G., et al.
Publicado: (2018)